Disorders Stocks List

Recent Signals

Date Stock Signal Type

Recent News for Disorders Stocks

Date Stock Title
Feb 25 NTUS Natus Medical Announces Fourth Quarter 2020 Financial Results
Feb 25 REGN ‘Covid-19 has been the perfect storm for adversaries’ in cybersecurity industry: CrowdStrike
Feb 25 NTUS Natus Medical, Inc. to Host Earnings Call
Feb 25 REGN Doctor: New COVID-19 strains come from ‘robust transmission of the virus’
Feb 25 REGN Positive news on COVID vaccines weighs against concerns over new variants
Feb 25 REGN Regeneron to share new data about COVID-19 antibody cocktail in March
Feb 25 BAX Why It's Time To Rotate Back To Baxter International
Feb 25 OMER Omeros Corporation to Announce Fourth Quarter and Year-End Financial Results on March 1, 2021
Feb 25 REGN Regeneron To Stop Giving Placebo In COVID-19 Antibody Trial After 'Clear Efficacy'
Feb 25 TNXP GME, AMC, TNXP and NGA among premarket gainers
Feb 25 ALBO Albireo Pharma EPS beats by $0.59, beats on revenue
Feb 25 ALBO Albireo Reports Q4 and Year-End 2020 Financial Results and Business Update
Feb 25 ITCI Intra-Cellular Therapies EPS beats by $0.09, beats on revenue
Feb 25 ITCI Intra-Cellular Therapies Reports Fourth Quarter and Full-Year 2020 Financial Results And Provides Corporate Update
Feb 25 OTIC Otonomy to Participate in Three Upcoming Investor Conferences
Feb 25 REGN Regeneron to stop giving placebo in COVID-19 drug trial after 'clear efficacy'
Feb 25 REGN Independent Data Monitoring Committee Finds Clear Efficacy for REGEN-COV™ (casirivimab with imdevimab) in Phase 3 COVID-19 Outpatient Outcomes Trial
Feb 25 CERC What Kind Of Investors Own Most Of Cerecor Inc. (NASDAQ:CERC)?
Feb 24 IONS Ionis Pharmaceuticals, Inc. (IONS) Q4 2020 Earnings Call Transcript
Feb 24 ITCI Intra-Cellular expands pipeline with a new therapy targeting dementia

Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

More about Disorders
Browse All Tags